Evidence map›Paper›PMID 38022543›Full record

ArticleFrontiers in immunology2023

Corrigendum: Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China.

Jingyun Tang, Humin Liu, Qing Wang, Xiaobo Gu, Jia Wang, Wenjun Li, Yinglan Luo, Yan Li, Lan Deng, Yue Luo and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Jingyun TangBlood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan, China.
Humin LiuDepartment of Blood Testing, Chengdu Blood Center, Chengdu, Sichuan, China.
Qing WangDepartment of Blood Collection, Chengdu Blood Center, Chengdu, Sichuan, China.
Xiaobo GuDepartment of Blood Collection, Chengdu Blood Center, Chengdu, Sichuan, China.
Jia WangDepartment of Blood Collection, Chengdu Blood Center, Chengdu, Sichuan, China.
Wenjun LiDepartment of Blood Testing, Chengdu Blood Center, Chengdu, Sichuan, China.
Yinglan LuoDepartment of Blood Testing, Chengdu Blood Center, Chengdu, Sichuan, China.
Yan LiDepartment of Blood Collection, Chengdu Blood Center, Chengdu, Sichuan, China.
Lan DengDepartment of Blood Collection, Chengdu Blood Center, Chengdu, Sichuan, China.
Yue LuoBlood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan, China.
Xinman DuBlood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan, China.
Donglin TanDepartment of Blood Processing, Chengdu Blood Center, Chengdu, Sichuan, China.
Xuemei Fu *Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan, China.
Xue Chen *Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1191479.].

Indexed as

Chineseconvalescent plasma screeningCOVID-19cross-sectional studySARS-CoV-2 IgG titerwhole-blood donors

Identifiers

PMID38022543
PMCPMC10660679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.